| Literature DB >> 27956093 |
Céline Dard1, Cathy Chemla2, Hélène Fricker-Hidalgo3, Marie-Pierre Brenier-Pinchart4, Marie Baret5, Alexandre Mzabi6, Isabelle Villena7, Hervé Pelloux8.
Abstract
Toxoplasma gondii is a protozoan parasite infecting up to one third of the world's population. T. gondii infection is usually benign in immunocompetent patients but can be life-threatening when congenitally transmitted. Congenital toxoplasmosis presentation ranges from severe central nervous system and ocular features, to a well appearing newborn with onset of complications late in childhood. The diagnosis of subclinical form remains important since early treatment reduces later complications such as chorioretinitis. We report an atypical case of congenital toxoplasmosis with a delayed diagnosis, based on Toxoplasma-specific serological follow-up. The infant was born to a mother who became infected during pregnancy, thus inducing infant biological and clinical follow-up. Neither biological nor clinical arguments favored a diagnosis of congenital toxoplasmosis until ten months of life. Congenital toxoplasmosis was then suspected because of an unusual increase of specific IgG levels. Diagnosis was confirmed by detection of newly synthesized newborn Ig isotypes using complementary comparative mother-to-child immunological profile techniques and specific treatment therefore administered. This report highlights the importance to follow up newborns at risk of congenital toxoplasmosis with specific and newborn-appropriate techniques until Toxoplasma-IgG titers are completely negative. This allows not only the exclusion of congenital toxoplasmosis when serology becomes negative, but also the diagnosis and treatment of congenital toxoplasmosis when infection is detected later in development.Entities:
Keywords: Compared Immunological Profiles; Congenital toxoplasmosis; Immunoassays; Serology; Toxoplasma gondii
Mesh:
Substances:
Year: 2016 PMID: 27956093 DOI: 10.1016/j.parint.2016.12.004
Source DB: PubMed Journal: Parasitol Int ISSN: 1383-5769 Impact factor: 2.230